4.8 Article

Population-level Metagenomics Uncovers Distinct Effects of Multiple Medications on the Human Gut Microbiome

期刊

GASTROENTEROLOGY
卷 163, 期 4, 页码 1038-1052

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.gastro.2022.06.070

关键词

Drug Combination; Polypharmacy; Gut Microbiota; Pathobiont; Gut Resistome

资金

  1. National Center for Global Health and Medicine [28-2401, 29-2001, 29-2004, 19A1011, 19A1022, 19A2015, 29-1025]
  2. Ministry of Health, Labour, and Welfare, Japan [19HB1003]
  3. JSPS KAKENHI Grant [JP17K09365, 20K08366]
  4. Smoking Research Foundation
  5. Takeda Science Foundation
  6. DANONE Research Grant
  7. COCKPIT funding

向作者/读者索取更多资源

This study found that many drugs, including non-antibiotics, have an impact on the human gut microbiome, especially in individuals who are exposed to multiple drugs. Polypharmacy leads to changes in gut microbiome structure and microbial functions, as well as an increase in antimicrobial resistance potential. The initiation and cessation of drugs also cause alterations and recovery in the microbiome.
BACKGROUND & AIMS: Medication is a major determinant of human gut microbiome structure, and its overuse increases the risks of morbidity and mortality. However, effects of certain commonly prescribed drugs and multiple medications on the gut microbiome are still underinvestigated. METHODS: We performed shotgun metagenomic analysis of fecal samples from 4198 individuals in the Japanese 4D (Disease, Drug, Diet, Daily life) microbiome project. A total of 759 drugs were profiled, and other metadata, such as anthropometrics, lifestyles, diets, physical activities, and diseases, were prospectively collected. Second fecal samples were collected from 243 individuals to assess the effects of drug initiation and discontinuation on the microbiome. RESULTS: We found that numerous drugs across different treatment categories influence the microbiome; more than 70% of the drugs we profiled had not been examined before. Individuals exposed to multiple drugs, polypharmacy, showed distinct gut microbiome structures harboring significantly more abundant upper gastrointestinal species and several nosocomial pathobionts due to additive drug effects. Polypharmacy was also associated with microbial functions, including the reduction of short-chain fatty acid metabolism and increased bacterial stress responses. Even nonantibiotic drugs were significantly correlated with an increased antimicrobial resistance potential through polypharmacy. Notably, a 2-time points dataset revealed the alteration and recovery of the microbiome in response to drug initiation and cessation, corroborating the observed drug-microbe associations in the cross-sectional cohort. CONCLUSION: Our large-scale meta-genomics unravels extensive and disruptive impacts of individual and multiple drug exposures on the human gut microbiome, providing a drug-microbe catalog as a basis for a deeper understanding of the role of the microbiome in drug efficacy and toxicity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据